Biotech funding rises 75% this year as M&A activity continues
Go back to Biotech funding rises 75% this year as M&A activity continues| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 251.10 +1.81 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.29 | 52 Week High | $160.00 | |||
| Open | $250.00 | 52 Week Low | $95.80 | |||
| Day High | $252.85 | P/E | 46.67 | |||
| Day Low | $246.99 | EPS | $5.38 | |||
| Volume | 4,764,257 | |||||
